-Hermann Einsele Researcher Activity Profile

Research Author Detailed Information 

Hermann Einsele Publication Rate By Year

Hermann Einsele has published 1 paper(s) in 2002, 3 paper(s) in 2006, 5 paper(s) in 2007, 12 paper(s) in 2008, for a total of 21 research publications in total.

Hermann H Einsele Author Information

LAST NAME: einsele

FIRST NAME: hermann

INITIALS: H

AFFILIATION:

Papers

Hermann Einsele's Publication Record

1. Impact of the intensity of the pretransplantation conditioning regimen in patients with prior invasive aspergillosis undergoing allogeneic hematopoietic stem cell transplantation: A retrospective survey of the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. Year Published: 2006
Hematology Department of Sant Pau Hospital, Autonomous University of Barcelona, Spain. rmartino@santpau.es
2. Lymphoid reconstruction and vaccines. Year Published: 2007
Experimental Transplantation and Immunology Branch, National Cancer Institute, NIH, Bethesda, Maryland, USA.
3. CMV-specific T cell therapy. Year Published: 2007
4. Modulation of glucose metabolism inhibits hypoxic accumulation of hypoxia-inducible factor-1alpha (HIF-1alpha). Year Published: 2007
Department of Radiotherapy, University of Wuerzburg, Germany. staab_a@klinik.uni-wuerzburg.de
5. Effects of HIF-1 inhibition by chetomin on hypoxia-related transcription and radiosensitivity in HT 1080 human fibrosarcoma cells. Year Published: 2008
6. Modulation of glucose metabolism inhibits hypoxic accumulation of hypoxia-inducible factor-1alpha (HIF-1alpha). Year Published: 2007
Department of Radiotherapy, University of Wuerzburg, Germany. staab_a@klinik.uni-wuerzburg.de
7. Polymorphisms in the chemokine (C-X-C motif) ligand 10 are associated with invasive aspergillosis after allogeneic stem-cell transplantation and influence CXCL10 epression in monocyte-derived dendritic cells. Year Published: 2008
8. A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma. Year Published: 2008
9. Adjusted dose lenalidomide is safe and effective in patients with deletion (5q) myelodysplastic syndrome and severe renal impairment. Year Published: 2008
10. Effects of HIF-1 inhibition by chetomin on hypoxia-related transcription and radiosensitivity in HT 1080 human fibrosarcoma cells. Year Published: 2008
11. Epstein-Barr viral load as a tool to diagnose and monitor post-transplant lymphoproliferative disease. Year Published: 2002
Department of Virology, University of Homburg, Homburg/Saar, Germany.
12. Induction of ERK-kinase signalling triggers morphotype-specific killing of Candida albicans filaments by human neutrophils. Year Published: 2008
University of Würzburg, Department of Internal Medicine II, Germany.
13. Polymorphisms in the chemokine (C-X-C motif) ligand 10 are associated with invasive aspergillosis after allogeneic stem-cell transplantation and influence CXCL10 expression in monocyte-derived dendritic cells. Year Published: 2008
Julius-Maximilians-Universität Würzburg, Medizinische Klinik und Poliklinik II, Germany.
14. A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma. Year Published: 2008
Department of Internal Medicine III, University of Munich, Germany.
15. Induction of ERK-kinase signalling triggers morphotype-specific killing of Candida albicans filaments by human neutrophils. Year Published: 2008
University of Würzburg, Department of Internal Medicine II, Germany.
16. CMV-specific T cell therapy. Year Published: 2007
Medizinische Klinik und Poliklinik II, Julius Maximilians University of Würzburg, Germany.
17. Effects of HIF-1 inhibition by chetomin on hypoxia-related transcription and radiosensitivity in HT 1080 human fibrosarcoma cells. Year Published: 2008
Department of Radiation Oncology, University of Würzburg, 97080 Würzburg, Germany. staab_a@klinik.uni-wuerzburg.de
18. Long-term CT follow-up in 40 non-HIV immunocompromised patients with invasive pulmonary aspergillosis: kinetics of CT morphology and correlation with clinical findings and outcome. Year Published: 2006
Department of Diagnostic Radiology, Eberhard-Karls-University, Hoppe-Seyler-Strasse 3, 72076 Tuebingen, Germany. hbrodoefel@t-online.de
19. Cytomegalovirus pneumonia after stem cell transplantation: correlation of CT findings with clinical outcome in 30 patients. Year Published: 2006
Department of Diagnostic Radiology, Eberhard-Karls-University, Hoppe-Seyler-Strasse 3, Tuebingen 72076, Germany. mshorger@med.uni-tuebingen.de
20. Adjusted dose lenalidomide is safe and effective in patients with deletion (5q) myelodysplastic syndrome and severe renal impairment. Year Published: 2008
21. Prospective oral mucositis audit: oral mucositis in patients receiving high-dose melphalan or BEAM conditioning chemotherapy--European Blood and Marrow Transplantation Mucositis Advisory Group. Year Published: 2008
Department of Hematology, University Medical Center St Radboud, PO Box 9101 6500 HB Nijmegen, The Netherlands. n.blijlevens@hemat.umcn.nl